Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Okubo

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Bone Reports|December 1, 2017
Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosisTeruki Sone, Naohiro Kon, Kenneth W Gaither, et al.
Plos One|November 14, 2013
Prolonged bioluminescence monitoring in mouse ex vivo bone culture revealed persistent circadian rhythms in articular cartilages and growth platesNaoki Okubo, Yoichi Minami, Hiroyoshi Fujiwara, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 26, 2021
Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumorsNoritoshi Kobayashi, Damian Wild, Felix Kaul, et al.
Cancers|July 27, 2022
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine TumorsSho Hasegawa, Noritoshi Kobayashi, Damian Wild, et al.
Acta Histochemica Et Cytochemica|February 9, 2016
Robust Circadian Rhythm and Parathyroid Hormone-Induced Resetting during Hypertrophic Differentiation in ATDC5 Chondroprogenitor CellsToshihiro Hosokawa, Yoshiki Tsuchiya, Naoki Okubo, et al.
Calcified Tissue International|August 26, 2020
Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with OsteoporosisNaoki Okubo, Shigeyuki Matsui, Toshio Matsumoto, et al.
Rheumatology (Oxford, England)|January 3, 2019
Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE studyNaoki Ishiguro, Yoshiya Tanaka, Hisashi Yamanaka, et al.
Annals of the Rheumatic Diseases|November 21, 2015
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trialTsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, et al.
Computer Methods in Biomechanics and Biomedical Engineering|October 17, 2024
Validation of patient-specific flatfoot models on finite element analysisYumiko Kobayashi, Kazuya Ikoma, Masahiro Maki, et al.
Spine Surgery and Related Research|April 16, 2026
Description of Scatter Radiation Exposure to the Eye Lenses and Direct Exposure to the Hands in Orthopedic and Spinal ProceduresYasukazu Hijikata, Kazuta Yamashita, Naoki Okubo, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Bone Reports|December 1, 2017
Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosisTeruki Sone, Naohiro Kon, Kenneth W Gaither, et al.
Plos One|November 14, 2013
Prolonged bioluminescence monitoring in mouse ex vivo bone culture revealed persistent circadian rhythms in articular cartilages and growth platesNaoki Okubo, Yoichi Minami, Hiroyoshi Fujiwara, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|June 26, 2021
Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumorsNoritoshi Kobayashi, Damian Wild, Felix Kaul, et al.
Cancers|July 27, 2022
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine TumorsSho Hasegawa, Noritoshi Kobayashi, Damian Wild, et al.
Acta Histochemica Et Cytochemica|February 9, 2016
Robust Circadian Rhythm and Parathyroid Hormone-Induced Resetting during Hypertrophic Differentiation in ATDC5 Chondroprogenitor CellsToshihiro Hosokawa, Yoshiki Tsuchiya, Naoki Okubo, et al.
Calcified Tissue International|August 26, 2020
Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with OsteoporosisNaoki Okubo, Shigeyuki Matsui, Toshio Matsumoto, et al.
Rheumatology (Oxford, England)|January 3, 2019
Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE studyNaoki Ishiguro, Yoshiya Tanaka, Hisashi Yamanaka, et al.
Annals of the Rheumatic Diseases|November 21, 2015
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trialTsutomu Takeuchi, Yoshiya Tanaka, Naoki Ishiguro, et al.
Computer Methods in Biomechanics and Biomedical Engineering|October 17, 2024
Validation of patient-specific flatfoot models on finite element analysisYumiko Kobayashi, Kazuya Ikoma, Masahiro Maki, et al.
Spine Surgery and Related Research|April 16, 2026
Description of Scatter Radiation Exposure to the Eye Lenses and Direct Exposure to the Hands in Orthopedic and Spinal ProceduresYasukazu Hijikata, Kazuta Yamashita, Naoki Okubo, et al.
Pageof 7